Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.

The Arthritis Therapy Acceleration Programme (A-TAP), led by Professor Chris Buckley, is an exciting project which champions an innovative approach to translational inflammation research through the application of unique rigorous signal seeking experimental medicine studies leading to rapid adoption into clinical trials underpinned by novel trial design.

In collaboration with

Supported by

Versus Arthritis logo

wellcome_trust_logo.png

  

NIHR